PharmaBlock Sciences Nanjing Inc
SZSE:300725

Watchlist Manager
PharmaBlock Sciences Nanjing Inc Logo
PharmaBlock Sciences Nanjing Inc
SZSE:300725
Watchlist
Price: 32.55 CNY 0.37% Market Closed
Market Cap: 6.5B CNY

Intrinsic Value

The intrinsic value of one PharmaBlock Sciences Nanjing Inc stock under the Base Case scenario is 39.98 CNY. Compared to the current market price of 32.55 CNY, PharmaBlock Sciences Nanjing Inc is Undervalued by 19%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
39.98 CNY
Undervaluation 19%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
PharmaBlock Sciences Nanjing Inc

Intrinsic Value History
Dive into the past to invest in the future

Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start now and learn if your stock is truly undervalued or overvalued!

Start Valuation
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
PharmaBlock Sciences Nanjing Inc
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for PharmaBlock Sciences Nanjing Inc cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

PharmaBlock Sciences Nanjing Inc
SZSE:300725
CN
Pharmaceuticals
Market Cap
6.5B CNY
IPO
Nov 10, 2017
CN
Pharmaceuticals
Market Cap
6.5B CNY
IPO
Nov 10, 2017
Price
ÂĄfalse
EPS
ÂĄfalse
Company Overview
Loading...
Management
Loading...
Contacts
Loading...
AI Assistant
AI Assistant
Ask me anything about PharmaBlock Sciences Nanjing Inc
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
PharmaBlock Sciences Nanjing Inc

Current Assets 2.7B
Cash & Short-Term Investments 1.4B
Receivables 493.6m
Other Current Assets 849.1m
Non-Current Assets 2.2B
Long-Term Investments 19.9m
PP&E 1.7B
Intangibles 463.7m
Other Non-Current Assets 50.6m
Efficiency

Free Cash Flow Analysis
PharmaBlock Sciences Nanjing Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
PharmaBlock Sciences Nanjing Inc

Revenue
1.8B CNY
Cost of Revenue
-1.2B CNY
Gross Profit
597m CNY
Operating Expenses
-371.5m CNY
Operating Income
225.5m CNY
Other Expenses
-19.7m CNY
Net Income
205.8m CNY
Fundamental Scores

Profitability Score
Profitability Due Diligence

PharmaBlock Sciences Nanjing Inc's profitability score is 47/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive 3-Years Revenue Growth
Positive Net Income
Positive Operating Income
47/100
Profitability
Score

PharmaBlock Sciences Nanjing Inc's profitability score is 47/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

PharmaBlock Sciences Nanjing Inc's solvency score is 67/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Low D/E
Long-Term Solvency
High Altman Z-Score
67/100
Solvency
Score

PharmaBlock Sciences Nanjing Inc's solvency score is 67/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
PharmaBlock Sciences Nanjing Inc

Wall Street analysts forecast PharmaBlock Sciences Nanjing Inc stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for PharmaBlock Sciences Nanjing Inc is 40.8 CNY with a low forecast of 40.4 CNY and a high forecast of 42 CNY.

Lowest
Price Target
40.4 CNY
24% Upside
Average
Price Target
40.8 CNY
25% Upside
Highest
Price Target
42 CNY
29% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for PharmaBlock Sciences Nanjing Inc is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest
What is the Intrinsic Value of one PharmaBlock Sciences Nanjing Inc stock?

The intrinsic value of one PharmaBlock Sciences Nanjing Inc stock under the Base Case scenario is 39.98 CNY.

Is PharmaBlock Sciences Nanjing Inc stock undervalued or overvalued?

Compared to the current market price of 32.55 CNY, PharmaBlock Sciences Nanjing Inc is Undervalued by 19%.

Back to Top